Phathom Pharmaceuticals Inc (PHAT)

7.50 -0.11 (-1.45%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Phathom Pharmaceuticals Historical Sharpe Ratio (5Y)

Historical Sharpe Ratio (5Y) Chart

View Historical Sharpe Ratio (5Y) for PHAT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Historical Sharpe Ratio (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Historical Sharpe Ratio Definition

View Historical Sharpe Ratio Definition
Start Trial

The Sharpe Ratio measures the risk-adjusted return of a security. This is a useful metric for analyzing the return you are receiving on a security in comparison to the amount of volatility expected. The historical sharpe ratio uses historical returns to calculate the return and standard deviation.

Read full definition.

Historical Sharpe Ratio (5Y) Range, Past 5 Years

View Historical Sharpe Ratio (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Historical Sharpe Ratio (5Y) Benchmarks

View Historical Sharpe Ratio (5Y) Benchmarks
Start Trial
Merck & Co Inc Upgrade
Galectin Therapeutics Inc Upgrade
AbbVie Inc Upgrade
Poseida Therapeutics Inc --
Janux Therapeutics Inc --

Historical Sharpe Ratio (5Y) Related Metrics

Alpha (5Y) Upgrade
Beta (5Y) Upgrade
Annualized Standard Deviation of Monthly Returns (5Y Lookback) Upgrade
Historical Sortino (5Y) Upgrade
Max Drawdown (5Y) Upgrade
Monthly Value at Risk (VaR) 5% (5Y Lookback) Upgrade